Package Service
| Class | Element technology |
|---|---|
| Initial ADME Panel | Caco-2 cell permeability Plasma protein binding Plasma stability Microsomal stability CYP inhibition |
| DDI (Drug-Drug interaction) Panel | Reaction phenotyping Transporter phenotyping CYP inhibition Time-dependent inhibition UGT inhibition Transporter inhibition Induction potential of CYP/UGT/Transporter |
| Peptide Panel | Plasma protein binding Plasma stability Microsomal stability CYP inhibition CYP induction |
좌우로 드래그 해보세요
Individual Service
| Class | Element technology |
|---|---|
| Met ID | Metabolites profiling and Met ID |
| Physicochemical properties | Solubility (kinetic, thermodynamic) |
| Permeability | PAMPA assay |
| Caco-2 cells permeability | |
| Plasma protein binding | Plasma protein binding assay |
| Protein binding | Plasma (Equilibrium dialysis, Ultrafiltration) |
| Albumin, Alpha-glycoprotein (Equilibrium dialysis, Ultrafiltration) | |
| Microsomal binding | |
| Metabolism study | Plasma stability |
| Microsomal stability | |
| Metabolite profiling and Met ID (in vitro) | |
| Metabolite profiling and Met ID (in vivo) | |
| Reactive metabolite formation (GSH trapping) | |
| CYP Phenotyping (CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 3A4/5) | |
| UGT Phenotyping (UGT1A1, 1A3, 1A4, 1A6, 1A9, 2B7, 2B15) | |
| Phenotyping_metabolite formation | |
| Non-CYP (FMO, CES, NAT, SULT 외) | |
| Transport study | ABC transport phenotyping (efflux transporters) |
| SLC transport phenotyping (uptake transporters) | |
| Peptide based uptake transport phenotyping (PEPT1/2, SMVT) | |
| SLC transport phenotyping in Xenopus oocytes (OATPs, OATs, OCTs, MATEs) | |
| Cryopreserved hepatocytes uptake | |
| Hepatic excretion by Sandwich cultured hepatocytes | |
| Drug metabollism Reaction phenotyping | Reaction phenotyping for CYP (recombinant CYPs) |
| Reaction phenotyping for UGT (recombinant UGTs) | |
| Drug transporter Reaction phenotyping | Reaction phenotyping for Transport |
| Reaction phenotyping for Transport (Kinetic study) | |
| Enzyme Inhibition | CYP Inhibition (Screening, IC50 assay) |
| CYP inhibition (Ki assay) | |
| UGT Inhibition (Screening, IC50 assay) | |
| UGT inhibition (Ki assay) | |
| Time-Dependent Inhibition (IC50 shift assay) | |
| Time-Dependent Inhibition (Ki and Kinact) | |
| Transporter Inhibition | Cytochrome P450 (CYP) time dependent inhibition (single point) assay |
| GSH conjugate (reactive metabolite) | |
| ABC transporter inhibition (efflux transporters_accumulation) | |
| ABC transporter inhibition (efflux transporters_bi-direction) | |
| SLC transporter inhibition (uptake transporters) | |
| Time-dependent inhibition of OATP, IC50 shift assay | |
| Enzyme/Transporter Induction | Cell viability |
| Transporter (CYPs, UGTs, Transporters) Induction | |
| Enzyme activity in human hepatocytes | |
| Enzyme Induction (EC50 assay) | |
| BCS-Biowaiver | Chemical stability |
| Caco-2 cell permeability | |
| Bioanalytical service | Method development |
| Method validation | |
| Sample analysis | |
| PK analysis | |
| Physicochemical properties | Solubility (kinetic, thermodynamic) |
좌우로 드래그 해보세요